Endo Pharmaceuticals gets green light for generic version of Plendil
Endo Pharmaceuticals (NASDAQ: ENDP) has received approval from the Food and Drug Administration for its drug Felodipine extended-release tablets, a generic version of AstraZeneca‘s (NYSE: AZN) drug, Plendil. The cardiovascular drug tallied $196 million in sales for AstraZeneca for the first nine months of 2011. The total sales for Felodipine in the U.S. for the […]